Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-14-022851

Options or other derivatives

  • Vice President & Secretary acquired 50,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

SEGALL JUDITH · Vice President & Secretary

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-03-20 Other acquisition : show line 1 in the form Option to Purchase Common Shares +50,000 $3.51 2021-03-19 50,000 50,000 D
Loading xslF345X03/doc4.xml…